SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-012882
Filing Date
2018-11-15
Accepted
2018-11-15 16:16:23
Documents
2
Period of Report
2018-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 3728
2 ex24mcavoy.txt EX-24 2101
  Complete submission text file 0001179110-18-012882.txt   7180
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Issuer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENDOCYTE, INC., 3000 KENT AVENUE SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
McAvoy David R. (Reporting) CIK: 0001758842 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35050 | Film No.: 181187429